Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer

Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer

We studied genomic alterations in 19 inflammatory breast cancer (IBC) patients with advanced disease using samples of tissue and paired blood serum or plasma (cell-free DNA, cfDNA) by targeted next generation sequencing (NGS). At diagnosis, the disease was triple negative (TN) in eleven patients (57...

Full description

Bibliographic Details
Main Authors: Jennifer S. Winn, Zachary Hasse, Michael Slifker, Jianming Pei, Sebastian M. Arisi-Fernandez, Jacqueline N. Talarchek, Elias Obeid, Donald A. Baldwin, Yulan Gong, Eric Ross, Massimo Cristofanilli, R. Katherine Alpaugh, Sandra V. Fernandez
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:International Journal of Molecular Sciences
Subjects:
inflammatory breast cancer (ibc)
cell-free dna (cfdna)
next generation sequencing (ngs)
Online Access:https://www.mdpi.com/1422-0067/21/4/1290

Internet

https://www.mdpi.com/1422-0067/21/4/1290

Similar Items